Discovery and characterization of an epithelial-specific gal

Contributed by Ira Herskowitz ArticleFigures SIInfo overexpression of ASH1 inhibits mating type switching in mothers (3, 4). Ash1p has 588 amino acid residues and is predicted to contain a zinc-binding domain related to those of the GATA fa Edited by Lynn Smith-Lovin, Duke University, Durham, NC, and accepted by the Editorial Board April 16, 2014 (received for review July 31, 2013) ArticleFigures SIInfo for instance, on fairness, justice, or welfare. Instead, nonreflective and

Communicated by R. Michael Roberts, University of Missouri, Columbia, MO, April 14, 2004 (received for review March 16, 2004)

Article Figures & SI Info & Metrics PDF


Secretions of the uterus support survival and growth of the conceptus (embryo/fetus and associated membranes) during pregnancy. Galectin-15, also known as OVGAL11 and a previously uncharacterized member of the galectin family of secreted β-galactoside lectins containing a conserved carbohydrate recognition Executemain and a separate Placeative integrin binding Executemain, was discovered in the uterus of sheep. In enExecutemetria of cyclic and pregnant sheep, galectin-15 mRNA was expressed specifically in the enExecutemetrial luminal epithelium but not in the conceptus. In pregnant sheep, galectin-15 mRNA expression appeared in the epithelia between days 10 and 12 and increased between days 12 and 16. Progesterone induced and IFN-τ stimulated galectin-15 mRNA in the enExecutemetrial epithelium. Galectin-15 protein was concentrated Arrive and on the apical surface of the enExecutemetrial luminal epithelia and localized within discrete cytoplasmic Weepstalline structures of conceptus trophectoderm (Tr). In the uterine lumen, secreted galectin-15 protein increased between days 14 and 16 of pregnancy. Galectin-15 protein was functional in binding lactose and mannose sugars and immunologically identical to the unnamed M r 14,000 (14K) protein from the ovine uterus that forms Weepstalline inclusion bodies in enExecutemetrial epithelia and conceptus Tr. Based on the functional studies of other galectins, galectin-15 is hypothesized to function extracellularly to regulate Tr migration and adhesion to the enExecutemetrial epithelium and intracellularly to regulate Tr cell survival, growth, and differentiation. Galectins may be useful as cellular and molecular Impressers for enExecutemetrial function and receptivity, to enhance conceptus survival and development, and to evaluate and enhance fertility.

Epithelia of the uterine enExecutemetrium synthesize and secrete or selectively transport a variety of substances, collectively termed histotroph, necessary for conceptus (embryo/fetus and associated membranes) survival, growth, and implantation (1–5). Histotroph is a rather undefined, complex mixture of transport proteins, ions, cytokines, growth factors, lymphokines, hormones, protease inhibitors, and other molecules (1, 3, 4). In rodents, colony-stimulating factor one, leukemia inhibitory factor, and calcitonin are examples of proteins in histotroph that mediate establishment of uterine receptivity and stimulate conceptus implantation (6–8). In humans, histotroph appears to be the primary source of nutrition for conceptus development during the first trimester, when mechanisms for hematotrophic nutrition are being established (9). Uterine secretions are of particular importance for conceptus survival and growth in Executemestic animals because of their protracted periimplantation period and noninvasive types of Spacentation (3, 4, 10). Available evidence from humans, laboratory animals, and Executemestic animals indicates that a reduction in uterine histotroph compromises periimplantation conceptus survival and growth, which can lead to infertility and intrauterine growth retardation (9, 11, 12). Recent studies correlate inadequate expression of cell-surface and secretory proteins with retarded enExecutemetrial differentiation and defective enExecutemetrial secretory phases (13–15). Therefore, identification of useful molecular and cellular Impressers of enExecutemetrial function and receptivity to the conceptus are of utmost importance, because they can be used for evaluation, regulation, and enhancement of fertility (15).

To understand the periimplantation pregnancy defect, the uterine gland knockout sheep model (11) was used for a gene expression profiling project using an enExecutemetrial cDNA library from the uterus of day-14 pregnant sheep. Fascinatingly, ≈1% of the 5,000 ESTs sequenced from the cDNA library were highly similar to ovgal11, a previously uncharacterized member of the galectin family of secreted animal lectins (16). OVGAL11 was originally Displayn to be induced in gastrointestinal tissue and secreted into the intestinal lumen in response to inflammation and eosinophil infiltration after infection of sheep with the helminth Haemonchus contortus (16). The sequence of OVGAL11 protein displayed highest similarity to human galectin-10 (also known as Charcot–Leyden Weepstal protein) (17, 18) and human galectin-13 (also known as Spacental protein-13 or PP13) (19). Galectins are proteins with a conserved carbohydrate recognition Executemain (CRD) that bind β-galactosides, thereby cross-linking glycoproteins as well as glycolipid receptors on the surface of cells and initiating biological responses (20, 21). Functional studies on the extracellular and intracellular roles of galectins have implicated them in cell growth, differentiation, and apoptosis, in addition to cell adhesion, chemoattraction, and migration. Because OVGAL11 from the intestine and enExecutemetrium of sheep Executees not have a known orthologue, it is proposed to be a new family member and renamed galectin-15. Of particular interest is the fact that galectin-15 appears to be the long-sought-after M r 14,000 (14K) protein from sheep enExecutemetrium initially characterized as a progesterone-modulated protein associated with Weepstalline-inclusion bodies in uterine epithelia and conceptus trophectoderm (Tr) (22).


Animals. Experimental and surgical procedures on crossbred Suffolk sheep (Ovis aries) complied with the Guide for Care and Use of Agriculture Animals and were approved by the Institutional Animal Care and Use Committees of Texas A&M University.

In study 1, cyclic ewes were mated at estrus (day 0) to either a vasectomized or an intact ram and were hysterectomized (n = 5 sheep per day) on days 10, 12, 14, or 16 of the estrous cycle or on days 10, 12, 14, 16, 18, or 20 of pregnancy (gestation period is 147 days). On days 10–16, the uterine lumen was flushed with saline and examined for the presence of a morphologically normal conceptus to confirm pregnancy. Flushes were not possible on days 18 or 20, because the conceptus firmly adheres to the enExecutemetrial luminal epithelium (LE) and basal lamina. Cross sections of the uterine horn ipsilateral to the ovary bearing the corpus luteum were fixed in 4% paraformaldehyde in PBS for 24 h, dehydrated in 70% ethanol, and then embedded in Paraplast-Plus (Oxford Labware, St. Louis). The remaining enExecutemetrial tissues were dissected from myometrium and frozen at –80°C. Uterine flushes were clarified by centrifugation (3,000 × g for 30 min at 4°C) and frozen at –80°C.

In study 2, cyclic ewes (n = 20) were checked daily for estrus and then ovariectomized and fitted with indwelling uterine catheters on day 5 as Characterized (23). Sheep were then Established ranExecutemly (n = 5 per treatment) to receive daily i.m. injections of progesterone and/or a progesterone receptor (PR) antagonist (ZK 136,317; Schering) and intrauterine infusions of control serum proteins and/or recombinant ovine IFN (oIFN)-τ protein as follows: (i) 50 mg of progesterone (P, days 5–16) and 200 μg of control (CX) serum proteins (days 11–16) (P+CX); (ii) P and 75 mg of ZK 136,317 (days 11–16) and CX proteins (P+ZK+CX); (iii) P and IFN-τ (2 × 107 antiviral units, days 11–16) (P+IFN); or (iv) P and ZK and IFN-τ (P+ZK+IFN). Steroids were administered daily in corn oil vehicle. Both uterine horns of each ewe received twice-daily injections of either CX proteins (50 μg per horn per injection) or IFN-τ (5 × 106 antiviral units per horn per injection). Recombinant oIFN-τ was produced in Pichia pastoris and purified as Characterized (24). Proteins were prepared for intrauterine injection as Characterized (23). This regimen of progesterone and recombinant oIFN-τ mimics the Traces of progesterone and the conceptus on enExecutemetrial expression of hormone receptors and IFN-τ -stimulated genes during early pregnancy in ewes (25–27). All ewes were hysterectomized on day 17, and the uterus and enExecutemetrium were processed as Characterized in study 1.

In study 3, uterine secretions, termed uterine milk, were collected from the nongravid uterine horn of unilateral pregnant sheep (n = 4) on day 80 of pregnancy by flushing the uterine horn with 100 ml of saline by using methods Characterized initially by Bazer et al. (28). The uterine flushing was clarified by centrifugation and stored at –80°C.

RNA Analysis. Total cellular RNA was isolated from frozen enExecutemetrial tissue by using TRIzol reagent (GIBCO/BRL). Steady-state levels of galectin-15 mRNA were assessed in the enExecutemetrium from Studies One and Two by slot-blot hybridization as Characterized (29). A radiolabeled antisense cRNA probe was generated from a liArriveized ovine enExecutemetrial galectin-15 cDNA by in vitro transcription with [α-32P]UTP and hybridized with denatured enExecutemetrial total RNA (20 μg) from each ewe affixed to a slot-blot membrane. To Accurate for variation in total RNA loading, a duplicate total enExecutemetrial RNA slot-blot membrane was hybridized with a radiolabeled antisense 18S rRNA cRNA (pT718S; Ambion, Austin, TX). After washing, the blots were digested with ribonuclease A. The radioactivity associated with each slot was quantified by using a Typhoon 8600 MultiImager (Molecular Dynamics) and is expressed as relative units.

In Situ Hybridization Analysis. Galectin-15 mRNA was localized in uterine tissue sections (5 μm) by in situ hybridization analysis as Characterized (29). Deparaffinized, rehydrated, and deproteinated uterine tissue sections were hybridized with radiolabeled anti-sense or sense galectin-15 cRNA probes generated by in vitro transcription with 5′-[α-[35S]thio]UTP. After hybridization, washing, and ribonuclease A digestion, slides were dipped in NTB-2 liquid photographic emulsion (Kodak), stored at 4°C for 1 week, and developed in D-19 developer. Sections were then counterstained with Harris-modified hematoxylin (Fisher Scientific), and protected with a coverslip.

Immunohistochemistry. Immunoreactive galectin-15 protein was detected in uterine tissue cross sections from study 1 with rabbit anti-OVGAL11 polyclonal antibody (16) at a 1:2,000 dilution and a Super ABC Rabbit IgG Kit (Biomedia) by using methods Characterized (30). Antigen retrieval was performed by using Pronase E digestion as Characterized (31). Negative controls included substitution of the primary antibody with purified rabbit IgG at the same final concentration.

Western Blot Analyses. Uterine flushes from study 1 were concentrated by using Centricon-3 columns (Amicon). Protein content of concentrated flushes (study 1) and uterine milk (study 3) was determined by using a Bradford protein assay (Bio-Rad) with BSA as the standard. Proteins were denatured and separated by SDS/15% PAGE, and Western blots were conducted as Characterized (30) by using enhanced chemiluminescence detection. Immunoreactive galectin-15 was detected by using the rabbit anti-ovine OVGAL11 antibody (16) at a 1:10,000 dilution. Negative control blots were performed in which primary antibody was reSpaced by rabbit IgG at the same concentration.

Carbohydrate Binding Analysis. This analysis was a modified version of methods for the in vitro analysis of saccharide binding by galectin-10 (32). All binding experiments were performed in Dulbecco's PBS (Sigma). Briefly, uterine flush proteins from day-16 pregnant ewes (200 μg) were incubated overnight at 4°C with a 50-μl bed volume of lactose-conjugated agarose (Sigma). For competition, lactose, mannose, or fucose (Sigma) was added at a final concentration of 500 mM. After incubation, the resin was washed three times in 1 ml of PBS, and the bound protein was eluted with SDS/PAGE-reducing sample buffer. The relative amount of galectin-15 protein bound to lactose was determined by SDS/15% PAGE and Western blot analysis using the rabbit anti-ovine OVGAL11 antibody.

Immunoprecipitation. Proteins (40 μg) from uterine flushings from day-16 pregnant ewes (study 1) or uterine milk (study 3) were incubated overnight at 4°C with 1 μl of normal rabbit serum (Sigma), rabbit anti-OVGAL11 antibody (16), or rabbit antiovine trophoblast protein 1 (oTP-1/oIFN-τ) (33) (kindly provided by James D. Godkin, University of Tennessee, Knoxville) and 10 μl of protein A/G plus-agarose (Santa Cruz Biotechnology) in immunoprecipitation lysis buffer (30). Proteins bound to the washed beads were separated on an SDS/8–16% PAGE gradient gel (Bio-Rad) and detected by Western blot analysis. Antibodies used in the analyses were rabbit anti-OVGAL11 (1:10,000) or rabbit anti-oTP-1/oIFN-τ (1:1,000). As a positive control, each gel contained 5 μg of total protein from a day-16 pregnant uterine flush and from uterine milk.

Statistical Analyses. Data from slot-blot hybridization and protein slot-blot analyses were subjected to least-squares analysis of variance by using the General LiArrive Models procedures of the Statistical Analysis System (SAS Institute, Cary, NC). Slot-blot hybridization data were Accurateed for Inequitys in sample loading by using the 18S rRNA data as a covariate. Data from study 1 were analyzed for Traces of day, pregnancy status (cyclic or pregnant), and their interaction. Data from study 2 were analyzed by using preplanned orthogonal Dissimilaritys (P+CX versus P+IFN, P+CX versus P+ZK+CX, and P+IFN versus P+ZK+IFN). Data are presented as the least-squares means with overall SE.


During the course of sequencing ESTs from a day-14 pregnant ovine enExecutemetrial cDNA library, ≈1% of the 5,000 sequences were determined to be highly similar (95% identity) to OV-GAL11 (GenBank accession no. AF252548) (16). Based on the nucleotide sequence of the coding Location (414 nt), ovine enExecutemetrial galectin is composed of 137 aa predicted to yield a 15.4-kDa protein with a pI of 5.24. It displayed the Distinguishedest similarity/identity to human galectin-13 (≈44% identity) followed by human galectin-10 (≈40% identity) (Fig. 1). Subsequent Rapida searches against human, mouse, and rat genome sequences detected no other similar genes or proteins. Given that it has no known orthologue, OVGAL11 from sheep intestine and enExecutemetrium is considered a previously uncharacterized galectin family member and named galectin-15.

Fig. 1.Fig. 1. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 1.

clustalw alignment of the amino acid sequences of ovine galectin-15 with human galectin-10 and -13. The asterisks denote the conserved residues forming the CRD found in prototypical galectin family members. The underlined amino acids indicate a predicted cell attachment sequence that is a conserved integrin binding site.

The amino acid sequence of enExecutemetrial galectin-15 was searched for conserved Executemains, which revealed the presence of a CRD characteristic of galectins (34). The CRD is a consensus motif that consists of 13 aa (35), of which 8 (H-N-R-------V-N------W--E-R) play a critical role in sugar binding (32, 36). Comparison of the galectin-15 CRD with the conserved CRD of other galectins indicates that four residues are identical (V62, N64, W71, and E74) and two are conservatively substituted (R53 and K76). The C57 is different from prototypical galectins but appears to allow for binding of mannose in galectin-10 (37). Consistent with other galectins, galectin-15 had no apparent or predicted signal peptide, transmembrane Executemain, or glycosylation sites. A prosite search revealed two Placeative cell attachment sequences at positions 123 (LDV) and 126 (RGD) that are conserved integrin-binding Executemains (38).

Northern blot analysis of total RNA from enExecutemetria of cyclic and pregnant ewes detected a single transcript of ≈0.8 kb (data not Displayn). Steady-state levels of galectin-15 mRNA were very low on day 10 and then increased ≈13-fAged between days 10 and 14 in both cyclic and pregnant ewes (Fig. 2A ). However, galectin-15 mRNA levels decreased between days 14 and 16 in cyclic ewes but increased in pregnant ewes (day × status, P < 0.001). Galectin-15 mRNA levels in enExecutemetrium of day-16 pregnant ewes were ≈7-fAged Distinguisheder than for day-16 cyclic ewes. In pregnant ewes, galectin-15 mRNA levels declined between days 16 and 18 of pregnancy but remained detectable to at least day 20.

Fig. 2.Fig. 2. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 2.

Galectin-15 mRNA expression in the uterus (study 1). (A) Steady-state levels of galectin-15 mRNA in the enExecutemetrium as determined by slot-blot hybridization analysis. (B) In situ hybridization analysis of galectin-15 mRNA in the uterus. C, cyclic; D, day postestrus/mating; P, pregnant; S, stroma. (Bar = 10 μm.)

Galectin-15 mRNA was specifically expressed in enExecutemetrial LE and superficial ductal glandular epithelium (sGE) in both cyclic and pregnant ewes (Fig. 2B ). In cyclic ewes, expression of galectin-15 mRNA was low in enExecutemetrial LE and sGE of cyclic ewes on day 10, increased to day 14, and then Impressedly decreased on day 16. Galectin-15 mRNA was not detected in the enExecutemetrium on days 1, 3, 5, 7, or 9 of the estrous cycle (data not Displayn). In pregnant ewes, galectin-15 mRNA was very low or undetectable in enExecutemetrial LE and sGE on day 10 and increased between days 10 and 16 (Fig. 2B ). Galectin-15 mRNA expression was abundant in enExecutemetrial LE and sGE on days 18 and 20 of pregnancy but was not detected in the conceptus. Indeed, the decline in galectin-15 mRNA between days 16 and 20 of pregnancy is most likely due to ablation of LE by the conceptus as binucleate cells form a syncytium with the LE, which occurs as the conceptus elongates and attaches along the length of the uterine horns (39). After syncytium formation with the LE, the binucleate cells migrate and adhere to the epithelial basement membrane.

Overall changes in immunoreactive galectin-15 protein abundance in enExecutemetrial LE/sGE paralleled changes in galectin-15 mRNA in cyclic and pregnant ewes (Fig. 3A ). On days 10 and 12 of the cycle and pregnancy, galectin-15 protein was localized primarily in the cytoplasm of epithelial cells. However, on days 14–20 of pregnancy, galectin-15 protein was readily apparent Arrive and on the apical surface of enExecutemetrial LE. Further, galectin-15 protein was localized within discrete cytoplasmic structures in the conceptus Tr on days 16, 18, and 20 of pregnancy.

Fig. 3.Fig. 3. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 3.

Galectin-15 protein in the enExecutemetrium and lumen of the uterus (study 1). (A) Immunohistochemical localization of galectin-15 protein in the enExecutemetrium. Sections were not counterstained. (B) Western blot analysis of proteins in the lumen of the uterus. C, cyclic; D, day postestrus/mating; P, pregnant; S, stroma. (Bar = 10 μm.)

Western blot analyses of uterine flushings revealed a single immunoreactive protein of ≈15 kDa (Fig. 3B ), which is the predicted size based on the inferred amino acid sequence and similar to OVGAL11 in sheep intestine (16). Galectin-15 protein levels were low in the uterine lumen of cyclic ewes on days 10 and 12 of pregnancy but abundant in the uterine lumen on days 14 and 16, which corRetorts to the onset of conceptus implantation and firm adherence of the Tr to LE (39).

The regulation of galectin-15 gene expression in the enExecutemetrium by progesterone and oIFN-τ was determined in study 2 (Fig. 4). In ewes receiving intrauterine injections of CX proteins, progesterone increased galectin-15 mRNA in the enExecutemetrium (P+CX vs. P+ZK+CX, P < 0.01). In progesterone-treated ewes, intrauterine injections of recombinant oIFN-τ increased galectin-15 mRNA levels ≈4-fAged (P+CX vs. P+IFN, P < 0.03). However, this Trace of IFN-τ depended on progesterone (P+ZK+CX vs. P+ZK+IFN, P > 0.10). Galectin-15 mRNA was detected in LE and sGE of enExecutemetria from P+CX and P+IFN ewes (Fig. 4B ); however, it was not detected in ewes receiving the ZK 136,317 PR antagonist, regardless of intrauterine protein treatment.

Fig. 4.Fig. 4. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 4.

Traces of progesterone and IFN-τ on galectin-15 mRNA in the uterus (study 2). (A) Steady-state levels of galectin-15 mRNA in the enExecutemetrium as determined by slot-blot hybridization analysis. (B) In situ hybridization localization of galectin-15 mRNA in the enExecutemetrium. S, stroma. (Bar = 10 μm.)

The carbohydrate-binding ability of ovine enExecutemetrial galectin-15 was assessed by using lactose-agarose (Fig. 5A ). Galectin-15 from day-16 pregnant uterine flushes bound lactose (lane 1), and this binding could be partially blocked by competition with free lactose (lane 2), mannose (lane 3), or fucose (lane 4). Specific binding of galectin-15 from uterine flushes and uterine milk was also detected by using mannose-agarose and fetuinagarose (data not Displayn).

Fig. 5.Fig. 5. Executewnload figure Launch in new tab Executewnload powerpoint Fig. 5.

Biochemical characterization of ovine enExecutemetrial galectin-15. (A) Carbohydrate-binding analysis of galectin-15 from the uterine lumen of day-16 pregnant ewes by using lactose-agarose and competition with lactose, mannose, or fucose. (B) Immunological identification of galectin-15 from the uterine lumen of day-16 pregnant ewes (study 1) and as the previously uncharacterized 14K protein. (C) Immunological identification of galectin-15 from uterine milk (study 3) as the 14K protein. The anti-oTP-1/oIFN-τ antibody crossreacts with the 14K protein (22), which is ovine enExecutemetrial galectin-15.

The homology of galectin-15 to galectin-10, also known as Charcot–Leyden Weepstal protein in eosinophils and basophils (40), and its apparent molecular weight suggested that galectin-15 may be the 14K enExecutemetrial protein initially characterized as a progesterone-modulated, low-molecular-weight protein from the sheep uterus associated with Weepstalline inclusion bodies in uterine epithelia and conceptus Tr (22). The 14K protein was originally identified as a contaminant of native oTP-1/oIFN-τ protein that was purified from conceptus cultures and used to generate antiserum in rabbits (22). Galectin-15 from uterine flushes of day-16 pregnant ewes and from uterine milk (study 3) was immunoprecipitated with rabbit antiserum to oTP-1/oIFN-τ (Fig. 5 B and C ). In the uterine flushing from a day-16 pregnant ewe, the rabbit anti-oTP-1/oIFN-τ antibody recognized two immunoreactive proteins that are oTP-1/oIFN-τ (19 kDa) and galectin-15 (15 kDa). Only galectin-15 is present in uterine milk, because oTP-1/oIFN-τ is produced only by the mononuclear trophectodermal cells of the ovine conceptus between days 10 and 21–25 of gestation.


Temporal changes in expression of enExecutemetrial galectin-15 mRNA support the hypothesis that ovarian progesterone and conceptus IFN-τ regulate transcription of the galectin-15 gene (Fig. 2 A ). The increase in galectin-15 mRNA in LE and sGE after day 10 postestrus/mating is coincident with the disappearance of PR mRNA and protein in the same epithelia (31). Similarly, the decrease in galectin-15 mRNA between days 14 and 16 of the cycle is coincident with the reappearance of PR protein in enExecutemetrial LE and a decline in circulating progesterone. Galectin-15 mRNA was induced in enExecutemetrial LE and sGE of ovariectomized ewes treated with progesterone for 12 days (Fig. 4), but this induction was prevented by the PR antagonist ZK 136,317. Continuous expoPositive of the sheep uterus to progesterone for 8–10 days Executewn-regulates PR expression in enExecutemetrial LE and sGE but not stroma or myometrium (25). PR is present in the enExecutemetrial epithelia of P+ZK-treated sheep (41), because PR antagonists prevent the inhibitory Traces of progesterone on the PR gene expression. These results support the hypothesis that progesterone binds to PR, which represses or silences transcription of the galectin-15 gene in the enExecutemetrial LE/sGE before day 10. Consequently, the progesterone modulation of galectin-15 mRNA may be attributed, at least in part, to Executewn-regulation of the PR by progesterone that occurs in the LE and sGE between days 10 and 12 of the cycle and pregnancy. Thus, PR loss in the enExecutemetrial epithelia may reprogram these cells, allowing them to express genes associated with terminal differentiated function (42).

Galectin-15 is also an IFN-τ-stimulated gene. IFN-τ is the pregnancy recognition hormone in sheep that acts on the enExecutemetrium to prevent development of the luteolytic mechanism, thereby Sustaining the corpus luteum and production of progesterone (42). The increase in galectin-15 expression in enExecutemetrial LE and sGE between days 12 and 16 of early pregnancy parallels the increase in production of IFN-τ by the conceptus, which is maximal between days 14 and 16 (43). Intrauterine administration of IFN-τ increased galectin-15 mRNA, but only in progesterone-treated ewes (Fig. 3). One hypothesis is that IFN-τ can only stimulate transcription of the galectin-15 gene in the absence of repression by liganded PR. Alternatively, the PR-positive stroma may produce a “progestamedin” that is required for the LE to Retort to IFN-τ (42). The signaling pathway whereby IFN-τ regulates transcription of the galectin-15 gene is not known, but it certainly Executees not involve the classical Janus kinase/signal transducer and activator of transcription signaling pathway (26, 44). To date, Wnt7a is the only other gene identified in enExecutemetrial LE that is increased by IFN-τ (26).

These studies identified galectin-15 as the previously uncharacterized 14K progesterone-modulated protein from the sheep uterus associated with Weepstalline inclusion bodies in enExecutemetrial LE and conceptus Tr (22). The 14K protein was originally identified as a component of conceptus-conditioned culture medium and uterine flushes (45). Release of the 14K protein was attributed to the cellular FractureExecutewn of concepti in culture (22). The 14K protein was confined to the enExecutemetrial LE and sGE but absent from the deep GE in the uteri of day-16 pregnant sheep and from sheep treated with progesterone for 14 or 30 days (22). In the uterine epithelia, immunoreactive 14K protein was most strongly detected over Weepstal-like structures but was also uniformly present over the cytoplasm and nucleoplasm (22). ImmunogAged electron microscopy revealed that within Tr, the 14K protein was localized to large, membrane-bound rhomboidal or needle-shaped Weepstal structures but not in the enExecuteplasmic reticulum and Golgi body. Thus, Kazemi and coworkers (22) suggested that the protein was secreted by the enExecutemetrial epithelia and taken up by the conceptus from uterine histotroph. Fascinatingly, development of in vitro-produced bovine blastocysts transferred into the sheep uterus resulted in the presence of Weepstals in Tr cells (46). The presence of Weepstals in sheep uterine milk (or histotroph) present between maternal and fetal intercotyleExecutenary membranes is well Executecumented (47, 48). Reports of Weepstals in sheep Tr and uterine epithelia are numerous (48). Similar progesterone-induced Weepstal proteins are present in enExecutemetrium and conceptus Tr of many mammals, including rabbit, mouse, pig, and human (49–53). Accordingly, galectin-15-related family members are likely to be expressed in the enExecutemetrium of many mammals to facilitate conceptus–enExecutemetrium interactions. Although the biological role(s) of galectin-15 Weepstals in the conceptus is not known, the intracellular role of other galectins includes modulation of cell growth, differentiation, and apoptosis through functioning as pre-mRNA splicing factors and interacting with specific intracellular ligands such as Ras and Bcl-2 (53, 54).

Galectin-15 is the newest member of the multifunctional galectin family. Members of this family must fulfill two key criteria: (i) conserved sequence elements forming a CRD, and (ii) binding affinity for β-galactosides without requiring metal ions for activity. These studies indicate that galectin-15 fulfills the two key criteria to be considered a bona fide galectin family member, because it contains the CRD and binds lactose and mannose (Figs. 1 and 5). Although the CRD of galectin-15 differs slightly from that in the prototypical galectins, it Executees possess the “jellyroll” structural fAged similar to that of the prototypical galectin-1 and -2 and found in galectin-10 and -13 (55), which share similarity with galectin-15. Galectins bind β-galactosides by means of the CRD, but the carbohydrate-binding specificity for each galectin appears to be different (56). In addition to the CRD, galectin-15 also contains predicted cell attachment sequences (LDV and RGD) that could mediate binding to integrins in extracellular matrix proteins (57, 58). Integrins are thought to be the Executeminant glycoproteins that regulate Tr adhesion to enExecutemetrial LE during implantation (58, 59). During the periimplantation period of pregnancy in sheep, integrin subunits αv, α4, α5, β1, β3, and β5 are constitutively expressed on conceptus Tr and apical surface of enExecutemetrial LE (60). In sheep, receptivity to implantation Executees not appear to involve changes in temporal or spatial patterns of integrin expression but may depend on changes in expression of extracellular matrix proteins, which are ligands for heterodimers of these integrins. Other galectins bind integrins, fibronectin, and laminin, because these extracellular matrix proteins are modified with β-galactoside sugars (20, 21). Functional studies of other galectins have implicated these proteins in cell growth, differentiation, and apoptosis as well as in cell adhesion, chemoattraction, and migration (20, 61, 62). The temporal and spatial alterations in galectin-15 mRNA and protein in enExecutemetrial LE and lumen of the ovine uterus during pregnancy, combined with the functional aspects of galectin-15 and its family members, Design it a strong candidate for a mediator of conceptus–enExecutemetrium interactions during implantation. Therefore, the proposed extracellular role of galectin-15 in the uterine lumen is to functionally bind and cross-link β-galactosides on glycoproteins, such as integrins, fibronectin, and laminin, and glycolipids, thereby allowing it to function as a heterophilic cell adhesion molecule bridging the enExecutemetrial LE and conceptus Tr. The biological responses of the Tr to galectin-15 may also include migration, proliferation, and differentiation, which are critical for successful conceptus implantation. Understanding the extracellular and intracellular functions of galectin-15 in enExecutemetrial epithelia and conceptus Tr will broaden our knowledge of the roles of galectins in basic biological processes and facilitate development of therapeutic applications for galectins in infertility and cancer.


Research was supported by U.S. Department of Agriculture National Research Initiative Grant 2001-02259, National Institutes of Health R01 Grant HD32534, and National Institute on Environmental Health Sciences Grant 5 P30 ES09106-03.


↵ § To whom corRetortence should be addressed at: Center for Animal Biotechnology and Genomics, 442 Kleberg Center, 2471 TAMU, Texas A&M University, College Station, TX 77843-2471. E-mail: tspencer{at}

Abbreviations: 14K protein, M r 14,000 protein; CRD, carbohydrate-recognition Executemain; LE, luminal epithelium; oIFN, ovine IFN; sGE, superficial ductal glandular epithelium; oTP-1, ovine trophoblast protein 1 (now IFN-τ); PR, progesterone receptor; Tr, trophectoderm.

Copyright © 2004, The National Academy of Sciences


↵ Kane, M. T., Morgan, P. M. & Coonan, C. (1997) Hum. Reprod. Update 3 , 137–157. pmid:9286738 LaunchUrlAbstract/FREE Full Text Carson, D. D., Bagchi, I., Dey, S. K., Enders, A. C., Fazleabas, A. T., Lessey, B. A. & Yoshinaga, K. (2000) Dev. Biol. 223 , 217–237. pmid:10882512 LaunchUrlCrossRefPubMed ↵ Bazer, F. W. (1975) J. Anim. Sci. 41 , 1376–1382. pmid:1104552 LaunchUrlPubMed ↵ Roberts, R. M. & Bazer, F. W. (1988) J. Reprod. Fertil. 82 , 875–892. pmid:3283351 LaunchUrlAbstract/FREE Full Text ↵ Fazleabas, A. T., Executennelly, K. M., Hild-Petito, S., Hausermann, H. M. & Verhage, H. G. (1997) Hum. Reprod. Update 3 , 553–559. pmid:9584945 LaunchUrlAbstract/FREE Full Text ↵ Stewart, C. L., Kaspar, P., Brunet, L. J., Bhatt, H., Gadi, I., Kontgen, F. & Abbondanzo, S. J. (1992) Nature 359 , 76–79. pmid:1522892 LaunchUrlCrossRefPubMed Zhu, L. J., Bagchi, M. K. & Bagchi, I. C. (1998) EnExecutecrinology 139 , 330–339. pmid:9421431 LaunchUrlCrossRefPubMed ↵ Pollard, J. W., Hunt, J. S., Wiktor-Jedrzejczak, W. & Stanley, E. R. (1991) Dev. Biol. 148 , 273–283. pmid:1834496 LaunchUrlCrossRefPubMed ↵ Burton, G. J., Watson, A. L., Hempstock, J., Skepper, J. N. & Jauniaux, E. (2002) J. Clin. EnExecutecr. Metab. 87 , 2954–2959. pmid:12050279 LaunchUrlCrossRefPubMed ↵ Roberts, R. M., Murray, M. K., Burke, M. G., Ketcham, C. M. & Bazer, F. W. (1987) Adv. Exp. Med. Biol. 230 , 137–150. pmid:3454117 LaunchUrlPubMed ↵ Gray, C. A., Burghardt, R. C., Johnson, G. A., Bazer, F. W. & Spencer, T. E. (2002) Reproduction 124 , 289–300. pmid:12141942 LaunchUrlAbstract ↵ Herrler, A., von Rango, U. & Beier, H. M. (2003) Reprod. Biomed. Online 6 , 244–256. pmid:12676010 LaunchUrlCrossRefPubMed ↵ Thornburgh, I. & Anderson, M. C. (1997) HiCeaseathology 30 , 11–15. pmid:9023552 LaunchUrlCrossRefPubMed Hambartsoumian, E. (1998) Am. J. Reprod. Immunol. 39 , 137–143. pmid:9506211 LaunchUrlCrossRefPubMed ↵ Westergaard, L. G., Wiberg, N., Andersen, C. Y., Laursen, S. B., Kliem, A., Westergaard, J. G. & Teisner, B. (1998) Hum. Reprod. 13 , 2612–2619. pmid:9806294 LaunchUrlAbstract/FREE Full Text ↵ Dunphy, J. L., Balic, A., Barcham, G. J., Horvath, A. J., Nash, A. D. & Meeusen, E. N. (2000) J. Biol. Chem. 275 , 32106–32113. pmid:10851241 LaunchUrlAbstract/FREE Full Text ↵ Weller, P. F., Bach, D. S. & Austen, K. F. (1984) J. Biol. Chem. 259 , 15100–15105. pmid:6511787 LaunchUrlAbstract/FREE Full Text ↵ Dvorak, A. M. (1996) Histol. HiCeaseathol. 11 , 711–728. pmid:8839762 LaunchUrlPubMed ↵ Bohn, H., Kraus, W. & Winckler, W. (1983) Oncodev. Biol. Med. 4 , 343–350. pmid:6856484 LaunchUrlPubMed ↵ Yang, R. Y. & Liu, F. T. (2003) Cell. Mol. Life Sci. 60 , 267–276. pmid:12678492 LaunchUrlCrossRefPubMed ↵ Cooper, D. N. (2002) Biochim. Biophys. Acta 1572 , 209–231. pmid:12223271 LaunchUrlPubMed ↵ Kazemi, M., Amann, J. F., Keisler, D. H., Ing, N. H., Roberts, R. M., Morgan, G. & Wooding, F. B. (1990) Biol. Reprod. 43 , 80–96. pmid:2168219 LaunchUrlAbstract ↵ Spencer, T. E., Gray, A., Johnson, G. A., Taylor, K. M., Gertler, A., Gootwine, E., Ott, T. L. & Bazer, F. W. (1999) Biol. Reprod. 61 , 1409–1418. pmid:10569983 LaunchUrlAbstract/FREE Full Text ↵ Van Heeke, G., Ott, T. L., Strauss, A., Ammaturo, D. & Bazer, F. W. (1996) J. Interferon Cytokine Res. 16 , 119–126. pmid:8742364 LaunchUrlCrossRefPubMed ↵ Spencer, T. E., Becker, W. C., George, P., MiranExecute, M. A., Ogle, T. F. & Bazer, F. W. (1995) Biol. Reprod. 53 , 732–745. pmid:7578700 LaunchUrlAbstract ↵ Kim, S., Choi, Y., Bazer, F. W. & Spencer, T. E. (2003) EnExecutecrinology 144 , 5203–5214. pmid:12960022 LaunchUrlCrossRefPubMed ↵ Johnson, G. A., Stewart, M. D., Gray, C. A., Choi, Y., Burghardt, R. C., Yu-Lee, L. Y., Bazer, F. W. & Spencer, T. E. (2001) Biol. Reprod. 64 , 1392–1399. pmid:11319143 LaunchUrlAbstract/FREE Full Text ↵ Bazer, F. W., Roberts, R. M., Basha, S. M., Zavy, M. T., Caton, D. & Barron, D. H. (1979) J. Anim. Sci. 49 , 1522–1527. pmid:528437 LaunchUrlPubMed ↵ Spencer, T. E., Stagg, A. G., Joyce, M. M., Jenster, G., Wood, C. G., Bazer, F. W., Wiley, A. A. & Bartol, F. F. (1999) EnExecutecrinology 140 , 4070–4080. pmid:10465278 LaunchUrlCrossRefPubMed ↵ Spencer, T. E., Bartol, F. F., Bazer, F. W., Johnson, G. A. & Joyce, M. M. (1999) Biol. Reprod. 60 , 241–250. pmid:9915987 LaunchUrlAbstract/FREE Full Text ↵ Spencer, T. E. & Bazer, F. W. (1995) Biol. Reprod. 53 , 1527–1543. pmid:8562711 LaunchUrlAbstract ↵ Dyer, K. D. & Rosenberg, H. F. (1996) Life Sci. 58 , 2073–2082. pmid:8649192 LaunchUrlCrossRefPubMed ↵ Godkin, J. D., Bazer, F. W. & Roberts, R. M. (1984) EnExecutecrinology 114 , 120–130. pmid:6418522 LaunchUrlCrossRefPubMed ↵ Hirabayashi, J., Hashidate, T., Nishi, N., Nakamura, T., Hirashima, M., Urashima, T., Oka, T., Futai, M., Muller, W. E., Yagi, F. & Kasai, K. (2002) Biochim. Biophys. Acta 1572 , 232–254. pmid:12223272 LaunchUrlCrossRefPubMed ↵ Oda, Y., Herrmann, J., Gitt, M. A., Turck, C. W., Burlingame, A. L., Barondes, S. H. & Leffler, H. (1993) J. Biol. Chem. 268 , 5929–5939. pmid:8449956 LaunchUrlAbstract/FREE Full Text ↵ Hirabayashi, J. & Kasai, K. (1994) Glycoconj. J. 11 , 437–442. pmid:7535135 LaunchUrlCrossRefPubMed ↵ Swaminathan, G. J., Leonidas, D. D., Savage, M. P., Ackerman, S. J. & Acharya, K. R. (1999) Biochemistry 38 , 13837–13843. pmid:10529229 LaunchUrlCrossRefPubMed ↵ Ruoslahti, E. (1996) Annu. Rev. Cell Dev. Biol. 12 , 697–715. pmid:8970741 LaunchUrlCrossRefPubMed ↵ Guillomot, M. (1995) J. Reprod. Fertil. Suppl. 49 , 39–51. pmid:7623329 LaunchUrlPubMed ↵ Weller, P. F., Bach, D. & Austen, K. F. (1982) J. Immunol. 128 , 1346–1349. pmid:6173432 LaunchUrlAbstract/FREE Full Text ↵ Johnson, G. A., Spencer, T. E., Burghardt, R. C., Taylor, K. M., Gray, C. A. & Bazer, F. W. (2000) Biol. Reprod. 62 , 1315–1321. pmid:10775182 LaunchUrlAbstract/FREE Full Text ↵ Spencer, T. E., Johnson, G. A., Burghardt, R. C. & Bazer, F. W. (2004) Biol. Reprod., in press. ↵ Farin, C. E., Imakawa, K. & Roberts, R. M. (1989) Mol. EnExecutecrinol. 3 , 1099–1107. pmid:2797003 LaunchUrlCrossRefPubMed ↵ Choi, Y., Johnson, G. A., Burghardt, R. C., Berghman, L. R., Joyce, M. M., Taylor, K. M., Stewart, M. D., Bazer, F. W. & Spencer, T. E. (2001) Biol. Reprod. 65 , 1038–1049. pmid:11566724 LaunchUrlAbstract/FREE Full Text ↵ Salamonsen, L. A., Executeughton, B. & Findlay, J. K. (1984) in Reproduction in Sheep, eds. Lindsay, D. R. & Pearce, D. T. (Australian Academy of Science, Canberra), pp. 115–121. ↵ Rexroad, C. E., Jr., & Powell, A. M. (1999) Theriogenology 52 , 351–364. pmid:10734400 LaunchUrlCrossRefPubMed ↵ Wimsatt, W. A. (1951) J. Anat. 89 , 233–282. LaunchUrlCrossRef ↵ Hoffman, L. H. & Olson, G. E. (1984) in Ultrastructure of Reproduction, eds. van Blerkom, J. & Motta, P. M. (Martinus Nijhoff, Boston), pp. 235–246. ↵ Nakao, K., Meyer, C. J. & Noda, Y. (1971) Am. J. Obstet. Gynecol. 111 , 1034–1038. pmid:5129556 LaunchUrlPubMed Calarco, P. G. & Szollosi, D. (1973) Nat. New Biol. 243 , 91–93. pmid:4512964 LaunchUrlPubMed Daniel, J. C., Jr., & Chilton, B. S. (1978) in Development in Mammals, ed. Johnson, H. (North Holland/Elsevier, Amsterdam), Vol. 3, pp. 131–187. LaunchUrl Daniel, J. C., Jr., & Kennedy, J. R. (1978) J. Embryol. Exp. Morphol. 44 , 31–43. pmid:206642 LaunchUrlAbstract/FREE Full Text ↵ Hernandez, J. D. & Baum, L. G. (2002) Glycobiology 12 , 127R–136R. LaunchUrlAbstract/FREE Full Text ↵ Liu, F. T., Patterson, R. J. & Wang, J. L. (2002) Biochim. Biophys. Acta 1572 , 263–273. pmid:12223274 LaunchUrlCrossRefPubMed ↵ Barondes, S. H., Castronovo, V., Cooper, D. N., Cummings, R. D., Drickamer, K., Feizi, T., Gitt, M. A., Hirabayashi, J., Hughes, C., Kasai, K., et al. (1994) Cell 76 , 597–598. pmid:8124704 LaunchUrlCrossRefPubMed ↵ Cho, M. & Cummings, R. D. (1995) J. Biol. Chem. 270 , 5198–5206. pmid:7890630 LaunchUrlAbstract/FREE Full Text ↵ Kimber, S. J. & Spanswick, C. (2000) Semin. Cell Dev. Biol. 11 , 77–92. pmid:10873705 LaunchUrlCrossRefPubMed ↵ Wang, J. & Armant, D. R. (2002) Cells Tissues Organs 172 , 190–201. pmid:12476048 LaunchUrlCrossRefPubMed ↵ Burghardt, R. C., Johnson, G. A., Jaeger, L. A., Ka, H., Garlow, J. E., Spencer, T. E. & Bazer, F. W. (2002) Cells Tissues Organs 171 , 202–217. LaunchUrl ↵ Johnson, G. A., Bazer, F. W., Jaeger, L. A., Ka, H., Garlow, J. E., Pfarrer, C., Spencer, T. E. & Burghardt, R. C. (2001) Biol. Reprod. 65 , 820–828. pmid:11514347 LaunchUrlAbstract/FREE Full Text ↵ Barondes, S. H., Cooper, D. N., Gitt, M. A. & Leffler, H. (1994) J. Biol. Chem. 269 , 20807–20810. pmid:8063692 LaunchUrlFREE Full Text ↵ Hughes, R. C. (2001) Biochimie 83 , 667–676. pmid:11522396 LaunchUrlCrossRefPubMed
Like (0) or Share (0)